Clinical Trial Update: Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC [Phase 2]

View source ↗

Summary

Phase II trial evaluating carboplatin, 5-FU, and cetuximab in elderly fit patients with recurrent/metastatic head and neck squamous cell carcinoma; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• 5-FU (5-fluorouracil)
• CARBOPLATIN (Carboplatin)
• Cetuximab (cetuximab)

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Metastatic or Recurrent Head and Neck Squamous Cell Cancer | Phase 2 | Status: COMPLETED